This article reviews studies using ultrasound contrast agents and discusses several of the contrast agents currently available. The anatomical areas that are enhanced by contrast, examination, and techniques, are used in imaging with contrast agents.
A contrast agent is a substance that enhances the image produced by medical diagnostic equipment such as ultrasound, x-ray, magnetic resonance, and nuclear medicine. Imaging is performed at specific time intervals after this substance is ingested, or injected intravenously, to enhance or increase contrast between anatomical structures. 1 The principal requirements for a contrast agent are that they be easily introducible into the vascular system, be stable for the duration of the diagnostic examination, have low toxicity, and modify one or more of the diagnostic properties of tissues that contribute to the ultrasound process. Most agents seek to enhance the echo by increasing as much as possible the backscatter of the tissue while increasing as little as possible the attenuation in the tissues.
There are 4 types of ultrasound contrast agents: oral, vascular, targeted or tissue specific, and therapeutic. 2 
Oral Agents
Oral agents can improve imaging of abdominal structures by absorbing and or displacing bowel gas. 1 One of the earliest oral agents was water. It was used to displace bowel gas and produce a "window" to improve visualization of anatomical structures, especially the pancreas. One of the newer contrast agents used today is SonoRx. [2] [3] [4] It is an orange-flavored, simethicone-coated cellulose contrast agent that forms a suspension exhibiting homogeneity, reflectivity, and cohesiveness in the gastrointestinal tract.
Vascular Contrast Agents
Vascular contrast agents consist of surfactant coated or encapsulated gas microbubbles less than 10 µm in diameter. These agents are injected into the bloodstream via a peripheral vein and then circulate through the body. Eventually, they are metabolized and eliminated by normal by-product elimination. 1 These agents significantly enhance the acoustic backscattering from blood in both color and spectral Doppler modes due to the large impedance between the gas and the surrounding blood. 5 The vascular contrast agents scatter ultrasound in a nonlinear manner and thereby introduce harmonics in the ultrasound signal. In harmonics, one transmits at the fundamental frequency but receives at the second harmonic frequency. In contrast, the nonlinearity of the contrast produces a "signature" that can be separated from tissue echoes, allowing capillary blood flow to be imaged. 6 Vascular contrast agents enhance the detection of blood flow and show organ and tissue perfusion, as well as the flow of blood into and out of an organ. They can better show the vascular pattern in and around tumors. Levovist (SHU 508A) is one of the vascular agents used today. It is a stable mixture consisting of 99.9% specially manufactured microcrystalline galactose microparticles and 0.1% palmatic acid. It is injected intravenously. 7 Vascular contrast agents can be given in a bolus or infusion technique. Studies have shown that infusion injections have proven to be more effective because the washout time is longer and more time is provided to image the contrast. It is thought that the uptake and washout of contrast over time may become important parameters helping to differentiate benign from malignant tumors. In an ultrasound contrast study, it was found that neovascular morphology and contrast times were statistically significant in discriminating between malignant and benign tumors.
Vascular contrast agents will most likely be used extensively in imaging the vascularity of tumors in the liver, kidney, ovary, pancreas, prostate, and breast. 6 
Tissue-Specific or Targeted Agents
Tissue-specific or targeted agents are focused on specific sites in the body. For example agents have been developed that adhere to a thrombus and can provide better imaging when looking for thrombosis in the vascular system. Agents that are phagocytized and remain intact in the Kupffer cells offer the prospect of a new kind of liver-imaging agent. 1 Sonovist is one type of targeted agent. It is a polymer particle with a gas-filled interior. After 15 to 20 minutes, the agent is taken up largely intact in the reticuloendothelial system. When imaged at peak pressures with Doppler, the bubbles are disrupted in the liver. The liver is imaged with color Doppler, and defects in Kupffer cells show an absence of the Doppler signals. 1 
Therapeutic Agents
Targeted agents are now being developed that, by combining the targeting of an agent with the ability to disrupt the bubbles in a selected area in the body, can deliver a method of drug delivery and treatment. 1 Thrombolytized agents are being developed that are housed in the microbubble shell. The acoustic energy ruptures the shell and the thrombolytic agent is released.
In the future, toxic cancer-fighting drugs will be able to destroy specific malignant tissues, sparing normal tissues and offering the patient the benefit of suffering fewer side effects and tissue damage during the treatment.
Anatomical Areas Imaged
Contrast has been used in cardiac imaging for years, but when using older contrast agents such as Albunex, there were stability problems. Some of the newer agents such as Definity and Sonazoid have overcome the stability problem. 6 Cardiac imaging using ultrasound contrast agents can allow assessment of the coronary arteries as well as collateral blood flow that may exist. 6 Studies using Imagent have shown a highly significant improvement in visualization of the walls of the heart as compared to standard ultrasound imaging. Studies using Levovist showed improvement in quantitative Doppler assessment of aortic stenosis, mitral regurgitation, and pulmonary venous flow. 1 As mentioned earlier, there are targeted agents used in liver imaging that are taken up by the Kupffer cells. There are also agents such as SHU 563A that are capable of circulating within the bloodstream and then are taken up by the reticuloendothelial system. These are used to enhance focal lesions in the liver and kidney. 8 Using Levovist, hepatocellular lesions showed hypervascular enhancement, and ultrasound vessels could be observed (comparable to computerized topography imaging with contrast). 9 There have been many clinical studies on contrast agents in renal imaging. Contrast enhancement shows promise in distinguishing benign from malignant lesions. Malignant lesions appear to have certain characteristics that are enhanced by contrast imaging. These are hypervascularity in and around the lesion and an increase in echogenicity of the lesion after contrast. 10 In a study using Definity, renal masses showed marked enhancement after contrast. And a study using wide-band harmonics showed small intraparenchymal lesions within 1 to 1.8 mm in diameter after blunt renal trauma. These were thought to be small subcapsular hematomas. 11 There are studies that attempt not only to better delineate renal masses but also to better define them as to malignant versus benign. Using the contrast agent SHU 563A, renal cell carcinoma showed a small amount of intramural signals, mostly at the margins and center of the lesion.
In the normal kidney, the parenchyma showed a polychromatic or monochromatic effect after injection of contrast. This was a filling effect caused by normal high blood perfusion of the kidney. But after injection of contrast, no intramural signals were seen in cystic lesions or abscesses.
Acute pyelonephritis is commonly shown in ultrasound as diffuse renal swelling, a focal or diffuse decrease in parenchymal echogenicity, loss of corticomedullary differentiation, and thickening of the renal pelvicalyceal system. With newer technology, the parenchymal defects were most commonly seen as focal or segmented patchy, low, echoic lesions extending from the renal medulla to the renal capsule. Using Levovist with color and power Doppler, the parenchymal changes were better defined. 12 For renal artery stenosis, Sonovue improved significantly the signal-to-noise ratio in the renal arteries, making it easier to image the renal arteries and better define a stenosis. In a study using Levovist, the time for duplex investigation of renal artery stenosis was cut in half. 1 In children, intraluminal Levovist instilled into the urinary bladder has been found to improve the ability of ultrasonography to detect vesicoureteral reflux. 6 The diagnosis of reflux was made when microbubbles appeared in the ureter or renal pelvis. 13 Using the contrast agent Echovist in hysterosalpingo contrast sonography for the evaluation of fallopian tube patency has been very successful. 11 In a study to diagnose ovarian malignancies, the brightness of power Doppler signal and the amount of recognizable vascular areas increased in each tumor after contrast administration. The contrast agent enhancement was significantly higher in malignant than benign adnexal masses. There was also an increase in the number of recognizable vessels after contrast agent administration. Contrast agent uptake times were significantly shorter in malignant than benign tumors. For differentiation of benign from malignant tumors, the kinetic properties of the contrast agent, such as uptake and washout times, have significant potential in diagnosing. 7 Doppler ultrasonography examination of breast tumors has revealed that cancerous lesions showed a higher number of vessels and that the color pixels persisted for longer periods of time. 7 The analysis of tissue intensity curves after Levovist injection might be useful to differentiate benign from malignant tumors in thyroid nodules. 14 Transcranial studies suffer from a poor signal-tonoise ratio, and the use of contrast agents such as Levovist has reduced the technical failure rate by as much as 80%. 1, 6 Oral contrast agents such as SonoRx have proven to be helpful in imaging abdominal organs such as the pancreas, spleen, and left kidney. 2, 7 Although using contrast agents to better image a specific organ might not be as exciting as using contrast to make the diagnosis, it is important to realize that the ability to better image an organ such as the pancreas can give the radiologist more confidence in ruling out an abnormality and eliminate the need for further, more expensive exams. 2 
Techniques
Multiple techniques have been used with contrast agents and have shown to improve the imaging of contrast agents. Some studies used only one of the techniques, such as pulse inversion, and other studies used multiple imaging techniques such as pulsed Doppler, power Doppler, and harmonics. There is a need for more studies done with contrast imaging to decide whether one technique is better than another, or whether the combination of several techniques will provide better results.
DOPPLER
The Doppler effect is a change in the frequency of echo signals that occurs whenever there is relative motion between the sound source and the reflector.
PULSED DOPPLER
Pulsed Doppler discriminates Doppler signals from different depths, allowing for the detection of moving interfaces and scatters from a well-defined volume. This defined volume is usually called the sample volume, which can be selected by the operator. In pulsed Doppler, the transducer is excited with a shortduration burst of energy. Scattered and reflected echo signals are detected by the same transducer between these bursts of energy. They are then amplified by the receiver and applied to a detector when the Doppler signal is obtained. By turning on the receiver for a short time interval at a specified time following each transmission of the burst, Doppler signals originating from a predetermined depth are selected for display and shown in a waveform pattern.
COLOR FLOW DOPPLER
In color flow Doppler, flow information determined from the Doppler measurement is displayed in features of the image itself. Stationary or slowly moving targets provide the basis for the image. Signal phase provides information about the presence and direction of motion, and changes in echo signal frequency relate to the velocity of the target. Backscattered signal from the red blood cells are displayed in color as a function of their motion toward or away from the transducers, and the degree of the saturation of the color is used to indicate the relative velocity of the moving red blood cells.
POWER MODE DOPPLER
Power mode Doppler uses a color map that displays the integrated power of the Doppler signal instead of its mean frequency shift. Because frequency shift data are not displayed, there is no aliasing. The image does not provide any information related to flow direction or velocity, and power mode Doppler imaging is much less angle dependent than frequency-based color Doppler. In contrast to color flow Doppler, where noise may appear in the image as any color, power mode Doppler permits noise to be assigned to a homogeneous background color that does not greatly interfere with the image. This results in a significant increase in the usable dynamic range of the scanner, permitting higher effective gain settings for flow detection and increased sensitivity. 1, 3 
HARMONIC IMAGING
Harmonics are frequencies that are integer multiples of the fundamental frequency and are quite common in acoustics. A fundamental frequency of 2 MHz will have its first harmonic at 4 MHz, the second at 8 MHz, the third at 16 MHz, and so on. Harmonics can be produced by tissues or by ultrasound contrast agents. Harmonics in tissue are not transmitted by the transducers but, rather, are generated by tissue during propagation of an acoustic pulse. Contrast agent harmonics, on the other hand, are generated by the injected contrast agent, typically microbubbles and not tissue. The microbubbles resonate when insonated, and it is this resonance that can generate harmonics, so that the echoes received from the resonating microbubbles contain fundamental and harmonic frequencies. This effect can be used to increase contrast agent brightness or visibility relative to tissue, thus enhancing the sensitivity of the contrast. Tissue harmonics are generated by tissue during the propagation of an acoustic pulse. Tissue harmonic imaging provides improved spatial and contrast resolution and contains fewer artifacts than conventional ultrasound. It is useful in evaluating difficult patients. 12 Contrast harmonics are produced by the resonance of the microbubbles when struck by the transmitted pulse. 15 Contrast harmonic imaging uses the nonlinear properties of contrast agents by transmitting at the fundamental frequency but receiving at the resonance frequency. A bubble acts as a harmonic oscillator, and contrastenhanced echo signals thus contain significant energy components at higher harmonics whereas tissue echoes do not. 6 The harmonic resonance measured with singletransducer systems may depend highly on the spectral characteristics of that transducer. The optimal transducer sensitivity at reception for the second harmonic is found at half the resonance frequency. The optimal rate for sensitivity at reception of the fundamental and second harmonics is found at one third of the transducer resonance frequency independent of the transducer bandwidth. 11, 15, 16 The diameter of the contrast agent microbubble will also affect the harmonic response. 16 The general concept of harmonic imaging is selective filtering of the second harmonic component, whose amplitude is displayed and shows only the presence of the contrast agent. 16 
FRAME-ONE IMAGING
Frame-one imaging is a method of capturing and displaying the maximum contrast enhancement within the cine-loop function to review the image data obtained with real-time imaging following a prolonged freeze frame. To perform frame-one imaging, the region of interest is placed in the center of the image, the ultrasound machine is placed in freeze frame, the contrast is given, and the freeze frame is released and then quickly activated again. Then, the operator can review the images in cine loop. 2, 17 Frame-one imaging does not need any new additions or upgrades with most machines because it uses the cine-loop function. 2, 17 
INTERMITTENT IMAGING
Intermittent imaging with high acoustic output uses the unique property of contrast microbubbles to improve blood-to-tissue image contrast by imaging intermittently, like frame-one imaging, at a very low frame rate instead of the 30 frames per second usually used. 10 Microbubbles can be destroyed by the acoustic field, and using intermittent imaging limits the interaction between the bubbles and the ultrasound pulse. This in turn improves contrast enhancement by imaging only at the maximum bubble concentration and allows for new bubbles to refill the region of interest before the next image frame is obtained. 5, 10, 18 
PULSE INVERSION IMAGING
This technique cancels out the first harmonic signal applied to grayscale as well as Doppler modes by transmitting a pulse sequence where each pulse is an inverted copy of the previous pulse. The sum of echoes from subsequent pulses will be zero. Echoes from stationary tissue will be suppressed. However, nonlinear echoes associated with contrast microbubbles will not cancel out and, thus, will be preferentially detected and displayed.
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3D IMAGING
3D imaging appears to be better suited than 2D ultrasound for demonstrating the chaotic tortuous vessels associated with tumor neovascularity. 5 
CONTRAST KINETICS
The uptake and washout of contrast over time, based on video densitometry, has been used to measure the myocardial transit time of the intravenously injected contrast microbubbles. Malignant tumors less than 3 mm in diameter stimulate the growth of new blood vessels by secreting angiogenesis factors, and this neovascularization can be an independent marker of malignancy. Ultrasound manufacturers are developing an automated method of detecting and recording uptake and washout times of the contrast agent, which can be used to differentiate tissue types in a manner similar to the traditional tracer methods used in nuclear medicine. 5 Kinetics were used 6 in the breast cancer study, and Spiezia et al 14 used time intensity curves to differentiate thyroid nodules.
Safety and Side Effects
The articles reviewed on contrast agents stated that there were very little to no side effects with the contrast agents used. There were no incidences of death or severe reactions noted in any of the studies. Some of the side effects that were noted were nausea, a flushing feeling, itchy eyes, diarrhea, pelvic pain, abdominal pain, back pain, and a case of tachycardia. 4, 7 It therefore appears that the contrast agents used in ultrasound are safe and have minor side effects.
Conclusion
The articles and studies reviewed showed that contrast imaging in ultrasound has great potential and that the use of contrast imaging in ultrasound might affect the use of ultrasound more than anything in the past. 19 Contrast imaging in ultrasound will enable us to image anatomical areas better and give the radiologist more confidence in determining whether an exam is abnormal or normal. It might allow us to distinguish between benign and malignant lesions. And it could even allow us to treat certain diseases using therapeutic contrast agents. Contrast imaging using contrast agents has the potential to do all this in an effective and efficient way, saving the patient from other more costly exams.
There are current barriers to widespread use of contrast agents: not all of the agents reviewed are FDA approved, and there is not yet any standardized reimbursement rate. Sonologists will be reluctant to provide the time and expense required for contrast studies unless they can be reimbursed for the added information. Another barrier is the lack of set standards and protocols providing guidance on when to use contrast, how to use contrast effectively, and how to interpret the information obtained. 19 
